These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 12654768

  • 21. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, Toye B.
    BMC Infect Dis; 2004 Sep 20; 4():36. PubMed ID: 15380025
    [Abstract] [Full Text] [Related]

  • 22. Quinolone resistance determinant qnrA3 in clinical isolates of Salmonella in 2000-2005 in Hong Kong.
    Chu YW, Cheung TK, Ng TK, Tsang D, To WK, Kam KM, Lo JY.
    J Antimicrob Chemother; 2006 Oct 20; 58(4):904-5. PubMed ID: 16943211
    [No Abstract] [Full Text] [Related]

  • 23. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.
    Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P.
    J Clin Microbiol; 1999 Nov 20; 37(11):3572-7. PubMed ID: 10523554
    [Abstract] [Full Text] [Related]

  • 24. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ, Toleman M, Walsh TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Jan 20; 54(1):13-21. PubMed ID: 16290025
    [Abstract] [Full Text] [Related]

  • 25. Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.
    Cebrián L, Rodríguez JC, Escribano I, Royo G.
    Chemotherapy; 2005 Mar 20; 51(1):40-3. PubMed ID: 15767744
    [Abstract] [Full Text] [Related]

  • 26. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA, Barrett TJ, Nelson JT, Angulo FJ.
    Clin Infect Dis; 2003 Jul 01; 37(1):75-81. PubMed ID: 12830411
    [Abstract] [Full Text] [Related]

  • 27. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.
    Escribano I, Rodríguez JC, Royo G.
    Int J Antimicrob Agents; 2004 Sep 01; 24(3):300-3. PubMed ID: 15325438
    [Abstract] [Full Text] [Related]

  • 28. Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones.
    Medders WM, Wooley RE, Gibbs PS, Shotts EB, Brown J.
    Avian Dis; 1998 Sep 01; 42(1):146-53. PubMed ID: 9533092
    [Abstract] [Full Text] [Related]

  • 29. Incidence of quinolone resistance in strains of Salmonella isolated from poultry, cattle and pigs in Germany between 1998 and 2001.
    Malorny B, Schroeter A, Guerra B, Helmuth R.
    Vet Rec; 2003 Nov 22; 153(21):643-8. PubMed ID: 14667084
    [Abstract] [Full Text] [Related]

  • 30. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
    Panhotra BR, Saxena AK, Al-Mulhim K.
    Jpn J Infect Dis; 2004 Jun 22; 57(3):116-8. PubMed ID: 15218222
    [Abstract] [Full Text] [Related]

  • 31. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
    Zafar A, Ibrahim NG, Ahsan T, Abbas Z, Zaidi A, Hasan R.
    J Coll Physicians Surg Pak; 2005 Jul 22; 15(7):413-7. PubMed ID: 16197870
    [Abstract] [Full Text] [Related]

  • 32. Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
    Delsol AA, Woodward MJ, Roe JM.
    J Antimicrob Chemother; 2004 Feb 22; 53(2):396-8. PubMed ID: 14711838
    [Abstract] [Full Text] [Related]

  • 33. Resistance to quinolones in Salmonella infantis due to overexpression of an active efflux system and a mutation in the gyrA gene.
    Merino LA, Alonso JM, Ruiz J, Vila J.
    Enferm Infecc Microbiol Clin; 2007 May 22; 25(5):357-8. PubMed ID: 17504693
    [No Abstract] [Full Text] [Related]

  • 34. Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005.
    Akiba M, Nakaoka Y, Kida M, Ishioka Y, Sameshima T, Yoshii N, Nakazawa M, Uchida I, Terakado N.
    J Antimicrob Chemother; 2007 Dec 22; 60(6):1235-42. PubMed ID: 17956907
    [Abstract] [Full Text] [Related]

  • 35. Nalidixic acid surrogate test for susceptibility to ciprofloxacin in Salmonella. Revisiting the question.
    Guzmán-Martín JL, Navarro-Marí JM, Expósito-Ruiz M, Gutiérrez-Fernández J.
    J Med Microbiol; 2018 Jul 22; 67(7):965-967. PubMed ID: 29767616
    [Abstract] [Full Text] [Related]

  • 36. In vitro susceptibility of multiple drug resistant Salmonella typhimurium to newer fluroquinolone derivatives.
    Shetty M, Shivananda PG.
    Indian J Pathol Microbiol; 1995 Oct 22; 38(4):365-8. PubMed ID: 9726145
    [Abstract] [Full Text] [Related]

  • 37. Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland.
    Lindgren MM, Kotilainen P, Huovinen P, Hurme S, Lukinmaa S, Webber MA, Piddock LJ, Siitonen A, Hakanen AJ.
    Emerg Infect Dis; 2009 May 22; 15(5):809-12. PubMed ID: 19402977
    [Abstract] [Full Text] [Related]

  • 38. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
    Capilla S, Ruiz J, Goñi P, Castillo J, Rubio MC, Jiménez de Anta MT, Gómez-Lus R, Vila J.
    J Antimicrob Chemother; 2004 Jun 22; 53(6):1068-71. PubMed ID: 15117921
    [Abstract] [Full Text] [Related]

  • 39. Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections.
    Al-Mashhadani M, Hewson R, Vivancos R, Keenan A, Beeching NJ, Wain J, Parry CM.
    Emerg Infect Dis; 2011 Jan 22; 17(1):123-5. PubMed ID: 21192872
    [Abstract] [Full Text] [Related]

  • 40. Antimicrobial resistance patterns of Campylobacter from feedlot cattle*.
    Englen MD, Fedorka-Cray PJ, Ladely SR, Dargatz DA.
    J Appl Microbiol; 2005 Jan 22; 99(2):285-91. PubMed ID: 16033459
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.